COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 255: Articles 2541-2550  | Next

A library-on-library screen reveals the breadth expansion landscape of a broadly neutralizing betacoronavirus antibody
Ornelas, M. Y., Ouyang, W. O., Wu, N. C.
10.1101/2024.06.06.597810 — Posted: 2024-06-10
Evaluating survey techniques in wastewater-based epidemiology for accurate COVID-19 incidence estimation
Murakami, M., Ando, H., Yamaguchi, R., Kitajima, M.
10.1101/2024.06.09.24308677 — Posted: 2024-06-10
Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: a serial cross-sectional study
Bagala, I., Namuganga, J. F., Nayebare, P., Cuu, G., Katairo, T., Nabende, I., Gonahasa, S., Nassali, M., Tukwasibwe, S., Dorsey, G., Nankabirwa, J. I., Kitaka, S., Kiguli, S., Greenhouse, B., Ssewanyana, I., Kamya, M. R., Briggs, J.
10.1101/2024.06.09.24308673 — Posted: 2024-06-10
Tocilizumab Reduces Hypercoagulation in COVID-19 - Perspectives from The Coagulation and Immunomodulation Covid Assessment (Coag-ImmCovA) Clinical Trial.
Almskog, L. M., Sjostrom, A., Sunden-Cullberg, J., Taxiarchis, A., Agren, A., Freyland, S., Borjesson, M., Wikman, A., Wahlgren, C. M., Wanecek, M., van der Linden, J., Antovic, J., Lampa, J., Magnusson, M.
10.1101/2024.05.31.24308108 — Posted: 2024-06-10
Virological characteristics of the SARS-CoV-2 KP.3, LB.1 and KP.2.3 variants
Kaku, Y., Yo, M. S., Tolentino, J. E., Uriu, K., Okumura, K., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ito, J., Sato, K.
10.1101/2024.06.05.597664 — Posted: 2024-06-09
Evidence for Behavioral Autorepression in Covid-19 Epidemiological Dynamics
Lewis, D. D., Pablo, M., Chen, X., Simpson, M. L., Weinberger, L.
10.1101/2024.06.07.24308626 — Posted: 2024-06-09
Workplace transmission of SARS-CoV-2 among health-care workers in Malaysia
Chan, Y. Y., Md Zoqratt, M. Z. H., Lau, N.-S., Musa, N., Khalid, M. F., Lim, S. Y., Wan Mohammad, W. M. Z., Rahman, S., Eng, W. W. H., Hussin, Z., Muhammad, A. H., Mohd Zain, M., Sulaiman, S., Mohd Fuzi, N. M. H., Mat Salleh, N. H., Omar, S., Halim, A. S., Deris, Z. Z., Banga Singh, K. K., Harun, A., Samsudin, M. N. F., Chua, W. L., Azmi, N. L., Engku Abd Rahman, E. N. S., Ahmed, N., Yaacob, N. A., Hamidun, A. R., Baharuddin, M. H., Nik Ab. Kadir, M. N., Hj Mahmud, M., Suliman, M. A., Ayub, Q., Hassan, R.
10.1101/2024.06.06.24306328 — Posted: 2024-06-09
Proteome-wide autoantibody screening and holistic autoantigenomic analysis unveil COVID-19 signature of autoantibody landscape
Matsuda, K. M., Kawase, Y., Iwadoh, K., Kurano, M., Yatomi, Y., Okamoto, K., Moriya, K., Kotani, H., Hisamoto, T., Kuzumi, A., Fukasawa, T., Yoshizaki-Ogawa, A., Kono, M., Okamura, T., Shoda, H., Fujio, K., Yamaguchi, K., Okumura, T., Ono, C., Kobayashi, Y., Sato, A., Miya, A., Goshima, N., Uchino, R., Murakami, Y., Matsunaka, H., Imai, H., Sato, S., Raymond, R., Yoshizaki, A.
10.1101/2024.06.07.24308592 — Posted: 2024-06-08
Increase in diagnoses associated with Post Acute Sequelae of COVID-19 (PASC) before and during the COVID-19 pandemic: a case-control study in the total population of Region Stockholm.
Lindberg, P., Ljunggren, G., Lee, S., Kolosenko, I., Runold, M., Piontkovskaya, K., Wachtler, C., Wheelock, A. M., Carlsson, A. C.
10.1101/2024.06.07.24308594 — Posted: 2024-06-08
Antibody response against SARS-CoV-2 spike protein in people with HIV after COVID-19 vaccination
Munoz-Gomez, M. J., Ryan, P., Quero-Delgado, M., Martin-Vicente, M., Cuevas, G., Valencia, J., Jimenez-Gonzalez, E., Blanca, N., Martinez de Gandara, A., Redondo, G., Mas, V., Vazquez, M., Torres-Macho, J., Martinez, I., Resino, S.
10.1101/2024.06.07.24308586 — Posted: 2024-06-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).